Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Ankur Drugs And Pharma Limited, is an unlisted public company incorporated on 09 February, 1995. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 28.00 cr and the total paid-up capital is INR 19.34 cr.
The current status of Ankur Drugs And Pharma Limited is - Under Liquidation.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
9.29%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
No Reports Available
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 2
Total Amount : 792.0 cr
Punjab National Bank
No. of Loans: 10
Total Amount : 190.8 cr
Central Bank of India
No. of Loans: 4
Total Amount : 170.0 cr
Syndicate Bank
No. of Loans: 2
Total Amount : 165.2 cr
State Bank of Indore
No. of Loans: 2
Total Amount : 128.7 cr
Axis Bank Limited
No. of Loans: 2
Total Amount : 85.0 cr
Corporation Bank
No. of Loans: 2
Total Amount : 74.0 cr
IDBI Bank Limited
No. of Loans: 3
Total Amount : 57.1 cr
CITI BANK N. A.
No. of Loans: 1
Total Amount : 45.0 cr
Indian Overseas Bank
No. of Loans: 2
Total Amount : 40.5 cr
IndusInd Bank Limited
No. of Loans: 2
Total Amount : 33.0 cr
Union Bank of India
No. of Loans: 2
Total Amount : 32.5 cr
The Shamrao Vithal Co-operative Bank Limited
No. of Loans: 4
Total Amount : 30.9 cr
ICICI Bank Limited
No. of Loans: 3
Total Amount : 30.0 cr
UCO Bank
No. of Loans: 1
Total Amount : 25.0 cr
Barclays Bank Plc
No. of Loans: 1
Total Amount : 25.0 cr
UNIT TRUST OF INDIA INVESTMENT ADVISORY SERVICES LIMITED
No. of Loans: 1
Total Amount : 24.5 cr
THE ORIENTAL BANK OF COMMERCE
No. of Loans: 1
Total Amount : 23.2 cr
The Sarawat Co-operative Bank Limited
No. of Loans: 1
Total Amount : 21.4 cr
Canara Bank
No. of Loans: 2
Total Amount : 21.0 cr
IFCI Factors Limited
No. of Loans: 2
Total Amount : 20.0 cr
Punjab and Sind Bank
No. of Loans: 1
Total Amount : 20.0 cr
S. E. INVESTMENTS LIMITED
No. of Loans: 4
Total Amount : 20.0 cr
SICOM Limited
No. of Loans: 1
Total Amount : 20.0 cr
3i Infotech Trusteeship Services Limited
No. of Loans: 1
Total Amount : 20.0 cr
Allahabad Bank
No. of Loans: 1
Total Amount : 19.5 cr
CORPORATION BANK-SME MAROL BRANCH
No. of Loans: 1
Total Amount : 19.4 cr
Bank of Bahrain & Kuwait B.S.C
No. of Loans: 1
Total Amount : 17.0 cr
IFCI VENTURE CAPITAL FUNDS LIMITED
No. of Loans: 1
Total Amount : 15.0 cr
Standard Chartered Bank
No. of Loans: 1
Total Amount : 15.0 cr
CORPROATION BANK
No. of Loans: 1
Total Amount : 12.5 cr
The South Indian Bank Limited
No. of Loans: 1
Total Amount : 12.0 cr
Bank of Rajasthan Limited
No. of Loans: 1
Total Amount : 10.0 cr
Centurion Bank of Punjab Ltd.
No. of Loans: 1
Total Amount : 10.0 cr
THE SHMRAO VITHAL CO-OP. BANK LTD.
No. of Loans: 2
Total Amount : 6.0 cr
Religare Finvest Limited
No. of Loans: 1
Total Amount : 2.0 cr
ALLBANK FINANCE LIMITED
No. of Loans: 1
Total Amount : 0.2 cr
BOMBAY MERCANTILE CO-OPERATIVE BANK LTD.
No. of Loans: 1
Total Amount : 0.1 cr
ALLBANK FINNACE LIMITED
No. of Loans: 1
Total Amount : 0.1 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Purnandu Shekharmal Jain | 00203799 | 28 years |
| Director | Dileep Himmatrao Shinde | 00270687 | 20 years |
| Director | Girraj Moolchand Vijayvargiya | 00815830 | 19 years |
| Kmp | Sanjay Chandrasen Rane | <HIDDEN> | 19 years |
| Director | Ramesh Balaram Batham | 01846197 | 14 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| VAIBHAV HEALTHCARE PRIVATE LIMITED |
Amalgamated
|
30.0 Cr | 2 | Maharashtra |
| BALKRISHNA PAPER MILLS LIMITED |
Active
|
10.7 Cr | 1 | Maharashtra |
| S B BATHAM TRADING PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| KARJAN ENTERPRISES PRIVATE LIMITED |
Amalgamated
|
1.4 L | 1 | Maharashtra |
| TUKAR ENTERPRISES PRIVATE LIMITED |
Amalgamated
|
1.4 L | 1 | Maharashtra |
| KORES (INDIA) LIMITED |
Active
|
13.0 Cr | 1 | Maharashtra |
The incorporation date of ANKUR DRUGS AND PHARMA LIMITED is 09 February, 1995
The authorized share capital of ANKUR DRUGS AND PHARMA LIMITED is INR ₹ 28.0 Cr.
The paid-up capital of ANKUR DRUGS AND PHARMA LIMITED is INR ₹ 19.3 Cr.
The registered address of ANKUR DRUGS AND PHARMA LIMITED is C-306, CRYSTAL PLAZA, ANDHERI LINK ROAD, ANDHERI (WEST) MUMBAI Mumbai City Maharashtra - 400053
The CIN number of ANKUR DRUGS AND PHARMA LIMITED is L24230MH1995PLC085410.
Expand
Delete
Collapse
See
details
